YOLFTbeta
68

Nanjing Vishee Medical Technology Co Ltd

688580 · SHG · Healthcare / Medical Devices

37.97CNY-0.79 (-2.04%)

Price History

Full chart

Market Stats

Previous Close38.76
Open38.64
Day Range37.88 – 39.50
52-Week Range39.80 – 70.81
Volume731.92K
Market Cap4.05B
P/E (TTM)23.87
Forward P/E0.00
EPS1.77
Dividend Yield2.56%
Beta0.47
50-Day Avg45.97
200-Day Avg54.09

About

Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) device, and MagNeuro ONE, a TMS therapy system with navigation for psychiatric and neurological applications. It also provides MagBelle, a pelvic floor muscle stimulator for the treatment of urinary incontinence, rehabilitation of weak pelvic muscles, and restoration of neuromuscular control; MagGraver, a powered muscle stimulator for use in abdominal sculpting and body sculpting applications; and RFIntima, a radiofrequency medical device. The company was founded in 2001 and is headquartered in Nanjing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Zhiyu Wang
  • Employees636
  • HeadquartersBuilding 9, Nanjing, China, 210012, China
  • Websitehttps://www.vishee.com

Leadership

  • Mr. Zhiyu WangGM & Chairman of the Board · b. 1967
  • Ms. Chen LiliDeputy GM, CFO & Director · b. 1980
  • Mr. Zhang HuiDeputy GM & Director · b. 1981
  • Ms. Yihong TongSenior Director of Strategic Investment Department & Secretary of the Board · b. 1985
  • Mr. Kai QiuDeputy General Manager · b. 1985
  • Mr. Fei GaoSenior Director of R&D Department · b. 1986
  • Mr. Chuan HanDeputy General Manager · b. 1980
  • Wenjing YaoAccounting Supervisor
  • Mr. Wenlong LiuMarketing Director · b. 1988

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue48.85M58.16M80.50M95.90M144.50M207.78M318.87M378.37M430.04M321.62M462.22M400.06M462.73M
Growth (%)-+19.05%+38.42%+19.13%+50.67%+43.80%+53.47%+18.66%+13.66%-25.21%+43.72%-13.45%+15.66%
Cost of Revenue15.32M17.34M21.89M25.55M38.39M53.69M83.83M99.76M108.45M88.52M149.16M138.26M156.46M
Gross Profit33.54M40.82M58.62M70.35M106.11M154.09M235.04M278.60M321.59M233.10M313.06M261.80M462.73M
Gross Margin68.65%70.18%72.81%73.36%73.43%74.16%73.71%73.63%74.78%72.48%67.73%65.44%100.00%
Operating Expense25.82M23.67M31.92M50.01M59.26M82.07M120.37M113.74M126.91M128.65M164.62M150.30M312.16M
Operating Income7.72M17.15M26.70M20.34M46.85M72.02M114.67M164.86M194.68M104.46M148.44M111.50M150.56M
Operating Margin15.80%29.48%33.16%21.21%32.42%34.66%35.96%43.57%45.27%32.48%32.11%27.87%32.54%
EBITDA15.35M23.82M31.16M18.96M47.49M77.65M123.64M175.29M207.46M122.13M170.28M134.68M172.76M
EBITDA Margin31.42%40.96%38.70%19.77%32.87%37.37%38.77%46.33%48.24%37.97%36.84%33.66%37.34%
Net Income13.99M21.75M28.13M23.15M40.34M63.36M99.72M143.66M177.81M93.83M136.26M101.97M136.63M
Net Income Margin28.64%37.40%34.94%24.14%27.92%30.50%31.27%37.97%41.35%29.17%29.48%25.49%29.53%
R&D1.82M--8.99M13.04M18.54M27.38M34.29M63.52M43.73M57.65M50.61M45.12M
R&D as % of Total Revenue3.72%--9.37%9.03%8.92%8.59%9.06%14.77%13.60%12.47%12.65%9.75%
Interest Expense-604.99K-28.27K33.51K611.75K887.49K412.75K184.70K334.05K1.32M1.31M1.31M
Interest Expense % of Total Revenue-1.04%-0.03%0.02%0.29%0.28%0.11%0.04%0.10%0.29%0.33%0.28%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets71.50M81.34M126.74M169.71M246.57M308.36M404.22M1.54B1.64B1.68B1.81B1.82B1.91B
Total Liabilities32.69M19.70M20.49M51.51M93.15M112.20M149.35M129.45M105.68M155.67M179.27M192.90M216.00M
Total Equity38.11M60.91M106.25M118.20M144.07M187.43M249.25M1.41B1.53B1.53B1.63B1.63B1.69B
Cash7.88M11.72M81.20M93.50M135.43M162.23M244.35M1.37B1.37B1.25B1.15B1.07B1.02B
Total Debt----20.00M19.50M14.00M4.17M2.99M1.19M27.10M896.83K-
Net Debt-7.88M-11.72M-81.20M-93.50M-115.43M-142.73M-230.35M-1.36B-1.36B-1.25B-1.15B-1.07B-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.23M15.01M25.22M30.98M52.35M85.84M141.47M120.76M157.37M86.17M134.20M118.29M176.74M
Investing Cash Flow-18.09M-11.56M27.16M-10.28M-12.69M-37.55M-16.90M1.85M-76.79M-104.80M-164.11M-100.82M-
Financing Cash Flow-2.52M381.09K17.11M-8.40M2.26M-21.49M-42.45M994.76M-80.99M-95.01M-63.96M-104.07M-
Capital Expenditure2.51M10.90M10.37M17.36M14.55M40.90M21.23M11.65M87.34M95.61M133.48M113.08M118.12M
Free Cash Flow5.72M4.11M14.85M13.62M37.80M44.94M120.24M109.11M70.02M-9.45M716.43K5.21M58.63M
Dividends Paid2.52M4.42M21.89M8.40M24.55M21.00M37.83M50.29M71.83M88.91M51.04M102.20M76.57M
FCF to OCF69.52%27.37%58.88%43.97%72.21%52.35%84.99%90.35%44.50%-10.96%0.53%4.41%33.17%
Dividend Paid to FCF44.02%107.58%147.43%61.67%64.94%46.72%31.46%46.09%102.58%-941.17%7124.06%1960.87%130.60%

Earnings

Report DateAug 25, 2020Oct 28, 2020Apr 28, 2021Jul 27, 2021Oct 27, 2021Apr 27, 2022Aug 28, 2022Oct 30, 2022Apr 25, 2023
EPS Estimate---------
EPS Actual0.540.510.460.560.550.250.310.350.44
Surprise---------
TimingPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap4.05B
Enterprise Value3.37B
Trailing P/E23.87
Forward P/E0.00
Price / Sales8.45
Price / Book2.50
EPS1.77
Book Value17.67
Revenue (TTM)478.71M
Gross Profit (TTM)316.83M
EBITDA163.05M
Profit Margin35.28%
Operating Margin32.39%
Return on Equity10.20%
Return on Assets4.82%
Shares Outstanding95.77M
Shares Float35.91M
Beta0.47
Dividend Yield2.56%
Dividend Rate1.08
Payout Ratio61.13%

Dividends

20261×
1.08Jun 18, 2026
20251×
0.80Jun 17, 2025
20241×
1.08Jun 5, 2024
20231×
0.49Jun 7, 2023
20221×
0.93Jun 14, 2022
20211×
0.75May 24, 2021

Stock Splits

  • Jun 5, 20241.4:1